Beyond cholesterol - inflammatory cytokines, the key mediators in atherosclerosis
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378892215 | ||
| 003 | CHVBK | ||
| 005 | 20180305123457.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040510xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/CCLM.2004.081 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2004.081 | ||
| 245 | 0 | 0 | |a Beyond cholesterol - inflammatory cytokines, the key mediators in atherosclerosis |h [Elektronische Daten] |c [Harald Mangge, Holger Hubmann, Stefan Pilz, Konrad Schauenstein, Wilfried Renner, Winfried März] |
| 520 | 3 | |a The development of atherosclerotic lesions encompasses a cascade of cellular and molecular responses that can at best be characterized as an inflammatory process, and exhibits striking similarities to autoimmune diseases, such as rheumatoid arthritis. Chemokines, cytokines and their receptors are critically involved in initiation and perpetuation of atherosclerosis, and they play important roles at all levels in the pathogenesis of this disease. In the present article, the currently available information on cytokines and chemokines as key mediators in atherosclerosis is reviewed. Furthermore, based on recent experiences of our own with very early stages of atherosclerosis, possible new ways to make use of these parameters toward improved early detection, prevention and treatment of this disease are indicated. | |
| 540 | |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Medical equipment & techniques |2 nationallicence | |
| 690 | 7 | |a Medical diagnosis |2 nationallicence | |
| 690 | 7 | |a Diseases & disorders |2 nationallicence | |
| 700 | 1 | |a Mangge |D Harald |4 aut | |
| 700 | 1 | |a Hubmann |D Holger |4 aut | |
| 700 | 1 | |a Pilz |D Stefan |4 aut | |
| 700 | 1 | |a Schauenstein |D Konrad |4 aut | |
| 700 | 1 | |a Renner |D Wilfried |4 aut | |
| 700 | 1 | |a März |D Winfried |4 aut | |
| 773 | 0 | |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 42/5(2004-05-10), 467-474 |x 1434-6621 |q 42:5<467 |1 2004 |2 42 |o cclm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/CCLM.2004.081 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/CCLM.2004.081 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Mangge |D Harald |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hubmann |D Holger |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Pilz |D Stefan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Schauenstein |D Konrad |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Renner |D Wilfried |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a März |D Winfried |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 42/5(2004-05-10), 467-474 |x 1434-6621 |q 42:5<467 |1 2004 |2 42 |o cclm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||